by Rajat Sharma | Jan 27, 2014 | equity, stocks, trading |
On the 24th of January 2014, as the markets opened for trade, Ranbaxy share price declined 20 % on news of U.S. Food & Drug Administration’s (USFDA) ban on the company from sending its drugs and ingredients into the United States (*from the company’s production...
by Rajat Sharma | Dec 9, 2013 | company, Consulting |
This is the part 2 of – this article on ICDR Regulations Let’s take the example of Confused Publicity Limited (“Issuer”). The Issuer is a media company primarily engaged in the business of writing about the lifestyle of the rich and famous and regularly features...
by Rajat Sharma | Dec 2, 2013 | Consulting |
As more and more promoters look to raise money by divesting equity in their business, the disclosure standards and regulations for listing on the stock exchanges are becoming increasingly stringent. The Securities and Exchange Board of India (“SEBI”) formulated...
